Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Por Yang, Liuting, Jiang, Xiaoyue, Yan, Han, Li, Yingying, Zhen, Hongchao, Chang, Bingmei, Kariminia, Seyed, Li, Qin
Publicado no BMC Gastroenterol (2018)